Insider: LEE LEO Director - INSMED Inc
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 126,465 | 0 | 126,465 |
| Value | $20,541,709.95 | $0.00 | $20,541,709.95 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 11/17/2025 | DDS | 3,212 | Direct | COM | $193.51 | $621,554.12 | 126,465 |
| 11/17/2025 | DDS | 17,594 | Direct | COM | $194.49 | $3,421,857.06 | 108,871 |
| 11/17/2025 | DDS | 14,944 | Direct | COM | $195.39 | $2,919,908.16 | 93,927 |
| 11/17/2025 | DDS | 15,174 | Direct | COM | $197.40 | $2,995,347.60 | 54,677 |
| 11/17/2025 | DDS | 24,076 | Direct | COM | $196.61 | $4,733,582.36 | 69,851 |
| 10/31/2022 | AAP | 45,000 | Direct | COM | $17.69 | $796,050.00 | 98,265 |
| 1 You are at page 1 of 1 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2026 Zacks Investment Research